English  |  正體中文  |  简体中文  |  總筆數 :2817371  
造訪人次 :  27748162    線上人數 :  179
教育部委託研究計畫      計畫執行:國立臺灣大學圖書館
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
關於TAIR

瀏覽

消息

著作權

相關連結

"ciou s c"的相關文件

回到依作者瀏覽
依題名排序 依日期排序

顯示項目 1-25 / 43 (共2頁)
1 2 > >>
每頁顯示[10|25|50]項目

機構 日期 題名 作者
臺大學術典藏 2022-09-05T06:38:51Z PCDH10 exerts tumor-suppressor functions through modulation of EGFR/AKT axis in colorectal cancer TZU-MING JAO; Fang W.-H.; Ciou S.-C.; Yu S.-L.; Hung Y.-L.; Weng W.-T.; Lin T.-Y.; Tsai M.-H.; Yang Y.-C.
臺大學術典藏 2021-10-04T07:15:53Z Role of repair protein Rad51 in regulating the response to gefitinib in human non-small cell lung cancer cells JEN-CHANG KO; Hong J.-H.; Wang L.-H.; Cheng C.-M.; Ciou S.-C.; Lin S.-T.; Jheng M.-Y.; Lin Y.-W.
臺大學術典藏 2021-10-04T07:15:53Z Involvement of Rad51 in cytotoxicity induced by epidermal growth factor receptor inhibitor (gefitinib, Iressa R) and chemotherapeutic agents in human lung cancer cells JEN-CHANG KO; Ciou S.-C.; Cheng C.-M.; Wang L.-H.; Hong J.-H.; Jheng M.-Y.; Ling S.-T.; Lin Y.-W.
臺大學術典藏 2021-10-04T07:15:53Z Roles of MKK1/2-ERK1/2 and phosphoinositide 3-kinase-AKT signaling pathways in erlotinib-induced Rad51 suppression and cytotoxicity in human non-small cell lung cancer cells JEN-CHANG KO; Ciou S.-C.; Jhan J.-Y.; Cheng C.-M.; Su Y.-J.; Chuang S.-M.; Lin S.-T.; Chang C.-C.; Lin Y.-W.
臺大學術典藏 2021-10-04T07:15:52Z Emodin enhances gefitinib-induced cytotoxicity via Rad51 downregulation and ERK1/2 inactivation Chen R.-S.; Jhan J.-Y.; Su Y.-J.; Lee W.-T.; Cheng C.-M.; Ciou S.-C.; Lin S.-T.; Chuang S.-M.; JEN-CHANG KO; Lin Y.-W.
臺大學術典藏 2021-10-04T07:15:52Z The role of celecoxib in Rad51 expression and cell survival affected by gefitinib in human non-small cell lung cancer cells JEN-CHANG KO; Wang L.-H.; Jhan J.-Y.; Ciou S.-C.; Hong J.-H.; Lin S.-T.; Lin Y.-W.
臺大學術典藏 2021-10-04T07:15:51Z Emodin enhances cisplatin-induced cytotoxicity via down-regulation of ERCC1 and inactivation of ERK1/2 JEN-CHANG KO; Su Y.-J.; Lin S.-T.; Jhan J.-Y.; Ciou S.-C.; Cheng C.-M.; Chiu Y.-F.; Kuo Y.-H.; Tsai M.-S.; Lin Y.-W.
臺大學術典藏 2021-10-04T07:15:51Z Suppression of ERCC1 and Rad51 expression through ERK1/2 inactivation is essential in emodin-mediated cytotoxicity in human non-small cell lung cancer cells JEN-CHANG KO; Su Y.-J.; Lin S.-T.; Jhan J.-Y.; Ciou S.-C.; Cheng C.-M.; Lin Y.-W.
臺大學術典藏 2021-03-11T08:34:31Z Involvement of Rad51 in cytotoxicity induced by epidermal growth factor receptor inhibitor (gefitinib, Iressa R) and chemotherapeutic agents in human lung cancer cells Jen-Chang Ko;Ciou S.-C.;Cheng C.-M.;Wang L.-H.;Hong J.-H.;Jheng M.-Y.;Ling S.-T.;Lin Y.-W.; JEN-CHANG KO; Ciou S.-C.; Cheng C.-M.; Wang L.-H.; Hong J.-H.; Jheng M.-Y.; Ling S.-T.; Lin Y.-W.
臺大學術典藏 2021-03-11T08:34:31Z Involvement of Rad51 in cytotoxicity induced by epidermal growth factor receptor inhibitor (gefitinib, Iressa R) and chemotherapeutic agents in human lung cancer cells Jen-Chang Ko;Ciou S.-C.;Cheng C.-M.;Wang L.-H.;Hong J.-H.;Jheng M.-Y.;Ling S.-T.;Lin Y.-W.; JEN-CHANG KO; Ciou S.-C.; Cheng C.-M.; Wang L.-H.; Hong J.-H.; Jheng M.-Y.; Ling S.-T.; Lin Y.-W.
臺大學術典藏 2021-03-11T08:34:30Z The role of celecoxib in Rad51 expression and cell survival affected by gefitinib in human non-small cell lung cancer cells Jen-Chang Ko;Wang L.-H.;Jhan J.-Y.;Ciou S.-C.;Hong J.-H.;Lin S.-T.;Lin Y.-W.; JEN-CHANG KO; Wang L.-H.; Jhan J.-Y.; Ciou S.-C.; Hong J.-H.; Lin S.-T.; Lin Y.-W.
臺大學術典藏 2021-03-11T08:34:30Z The role of celecoxib in Rad51 expression and cell survival affected by gefitinib in human non-small cell lung cancer cells Jen-Chang Ko;Wang L.-H.;Jhan J.-Y.;Ciou S.-C.;Hong J.-H.;Lin S.-T.;Lin Y.-W.; JEN-CHANG KO; Wang L.-H.; Jhan J.-Y.; Ciou S.-C.; Hong J.-H.; Lin S.-T.; Lin Y.-W.
臺大學術典藏 2021-03-11T08:34:30Z Roles of MKK1/2-ERK1/2 and phosphoinositide 3-kinase-AKT signaling pathways in erlotinib-induced Rad51 suppression and cytotoxicity in human non-small cell lung cancer cells Jen-Chang Ko;Ciou S.-C.;Jhan J.-Y.;Cheng C.-M.;Su Y.-J.;Chuang S.-M.;Lin S.-T.;Chang C.-C.;Lin Y.-W.; JEN-CHANG KO; Ciou S.-C.; Jhan J.-Y.; Cheng C.-M.; Su Y.-J.; Chuang S.-M.; Lin S.-T.; Chang C.-C.; Lin Y.-W.
臺大學術典藏 2021-03-11T08:34:30Z Roles of MKK1/2-ERK1/2 and phosphoinositide 3-kinase-AKT signaling pathways in erlotinib-induced Rad51 suppression and cytotoxicity in human non-small cell lung cancer cells Jen-Chang Ko;Ciou S.-C.;Jhan J.-Y.;Cheng C.-M.;Su Y.-J.;Chuang S.-M.;Lin S.-T.;Chang C.-C.;Lin Y.-W.; JEN-CHANG KO; Ciou S.-C.; Jhan J.-Y.; Cheng C.-M.; Su Y.-J.; Chuang S.-M.; Lin S.-T.; Chang C.-C.; Lin Y.-W.
臺大學術典藏 2021-03-11T08:34:30Z Role of repair protein Rad51 in regulating the response to gefitinib in human non-small cell lung cancer cells Jen-Chang Ko;Hong J.-H.;Wang L.-H.;Cheng C.-M.;Ciou S.-C.;Lin S.-T.;Jheng M.-Y.;Lin Y.-W.; JEN-CHANG KO; Hong J.-H.; Wang L.-H.; Cheng C.-M.; Ciou S.-C.; Lin S.-T.; Jheng M.-Y.; Lin Y.-W.
臺大學術典藏 2021-03-11T08:34:30Z Role of repair protein Rad51 in regulating the response to gefitinib in human non-small cell lung cancer cells Jen-Chang Ko;Hong J.-H.;Wang L.-H.;Cheng C.-M.;Ciou S.-C.;Lin S.-T.;Jheng M.-Y.;Lin Y.-W.; JEN-CHANG KO; Hong J.-H.; Wang L.-H.; Cheng C.-M.; Ciou S.-C.; Lin S.-T.; Jheng M.-Y.; Lin Y.-W.
臺大學術典藏 2021-03-11T08:34:29Z Emodin enhances gefitinib-induced cytotoxicity via Rad51 downregulation and ERK1/2 inactivation Chen R.-S.;Jhan J.-Y.;Su Y.-J.;Lee W.-T.;Cheng C.-M.;Ciou S.-C.;Lin S.-T.;Chuang S.-M.;Jen-Chang Ko;Lin Y.-W.; Chen R.-S.; Jhan J.-Y.; Su Y.-J.; Lee W.-T.; Cheng C.-M.; Ciou S.-C.; Lin S.-T.; Chuang S.-M.; JEN-CHANG KO; Lin Y.-W.
臺大學術典藏 2021-03-11T08:34:29Z Emodin enhances gefitinib-induced cytotoxicity via Rad51 downregulation and ERK1/2 inactivation Chen R.-S.;Jhan J.-Y.;Su Y.-J.;Lee W.-T.;Cheng C.-M.;Ciou S.-C.;Lin S.-T.;Chuang S.-M.;Jen-Chang Ko;Lin Y.-W.; Chen R.-S.; Jhan J.-Y.; Su Y.-J.; Lee W.-T.; Cheng C.-M.; Ciou S.-C.; Lin S.-T.; Chuang S.-M.; JEN-CHANG KO; Lin Y.-W.
臺大學術典藏 2021-03-11T08:34:29Z Suppression of ERCC1 and Rad51 expression through ERK1/2 inactivation is essential in emodin-mediated cytotoxicity in human non-small cell lung cancer cells Jen-Chang Ko;Su Y.-J.;Lin S.-T.;Jhan J.-Y.;Ciou S.-C.;Cheng C.-M.;Lin Y.-W.; JEN-CHANG KO; Su Y.-J.; Lin S.-T.; Jhan J.-Y.; Ciou S.-C.; Cheng C.-M.; Lin Y.-W.
臺大學術典藏 2021-03-11T08:34:29Z Suppression of ERCC1 and Rad51 expression through ERK1/2 inactivation is essential in emodin-mediated cytotoxicity in human non-small cell lung cancer cells Jen-Chang Ko;Su Y.-J.;Lin S.-T.;Jhan J.-Y.;Ciou S.-C.;Cheng C.-M.;Lin Y.-W.; JEN-CHANG KO; Su Y.-J.; Lin S.-T.; Jhan J.-Y.; Ciou S.-C.; Cheng C.-M.; Lin Y.-W.
臺大學術典藏 2021-03-11T08:34:28Z Emodin enhances cisplatin-induced cytotoxicity via down-regulation of ERCC1 and inactivation of ERK1/2 Jen-Chang Ko;Su Y.-J.;Lin S.-T.;Jhan J.-Y.;Ciou S.-C.;Cheng C.-M.;Chiu Y.-F.;Kuo Y.-H.;Tsai M.-S.;Lin Y.-W.; JEN-CHANG KO; Su Y.-J.; Lin S.-T.; Jhan J.-Y.; Ciou S.-C.; Cheng C.-M.; Chiu Y.-F.; Kuo Y.-H.; Tsai M.-S.; Lin Y.-W.
臺大學術典藏 2021-03-11T08:34:28Z Emodin enhances cisplatin-induced cytotoxicity via down-regulation of ERCC1 and inactivation of ERK1/2 Jen-Chang Ko;Su Y.-J.;Lin S.-T.;Jhan J.-Y.;Ciou S.-C.;Cheng C.-M.;Chiu Y.-F.;Kuo Y.-H.;Tsai M.-S.;Lin Y.-W.; JEN-CHANG KO; Su Y.-J.; Lin S.-T.; Jhan J.-Y.; Ciou S.-C.; Cheng C.-M.; Chiu Y.-F.; Kuo Y.-H.; Tsai M.-S.; Lin Y.-W.
臺大學術典藏 2021-03-11T08:29:43Z Involvement of Rad51 in cytotoxicity induced by epidermal growth factor receptor inhibitor (gefitinib, Iressa R) and chemotherapeutic agents in human lung cancer cells Jen-Chang Ko;Ciou S.-C.;Cheng C.-M.;Wang L.-H.;Hong J.-H.;Jheng M.-Y.;Ling S.-T.;Lin Y.-W.; JEN-CHANG KO; Ciou S.-C.; Cheng C.-M.; Wang L.-H.; Hong J.-H.; Jheng M.-Y.; Ling S.-T.; Lin Y.-W.
臺大學術典藏 2021-03-11T08:29:43Z Involvement of Rad51 in cytotoxicity induced by epidermal growth factor receptor inhibitor (gefitinib, Iressa R) and chemotherapeutic agents in human lung cancer cells Jen-Chang Ko;Ciou S.-C.;Cheng C.-M.;Wang L.-H.;Hong J.-H.;Jheng M.-Y.;Ling S.-T.;Lin Y.-W.; JEN-CHANG KO; Ciou S.-C.; Cheng C.-M.; Wang L.-H.; Hong J.-H.; Jheng M.-Y.; Ling S.-T.; Lin Y.-W.
臺大學術典藏 2021-03-11T08:29:42Z The role of celecoxib in Rad51 expression and cell survival affected by gefitinib in human non-small cell lung cancer cells JEN-CHANG KO; Wang L.-H.; Jhan J.-Y.; Ciou S.-C.; Hong J.-H.; Lin S.-T.; Lin Y.-W.

顯示項目 1-25 / 43 (共2頁)
1 2 > >>
每頁顯示[10|25|50]項目